AACR Annual Meeting 2021 Acute Lymphoblastic Leukemia ASH Leukemia ASH Street Team Biochemical Recurrence in Prostate Cancer R/R HER2+ Metastatic Breast Cancer Case Review

AACR Annual Meeting 2021Acute Lymphoblastic LeukemiaASH LeukemiaASH Street TeamBiochemical Recurrence in Prostate Cancer R/R HER2+ Metastatic Breast Cancer Case Review

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

All News NP/PA Practice Management Technology

All NewsNP/PAPractice ManagementTechnology

Media

Around the Practice Clinical Consult Enduring Webinars Expert Interviews Medical World News OncView Podcasts Readout 360 Tumor Board Series

Around the PracticeClinical ConsultEnduring WebinarsExpert InterviewsMedical World NewsOncViewPodcastsReadout 360Tumor Board Series

Conferences

Publications

About Oncology Journal Oncology Journal

About Oncology JournalOncology Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Image IQ Polls Quizzes Slideshows Sponsored Toolkits

Image IQPollsQuizzesSlideshowsSponsoredToolkits

eNewsletter Print Subscription

eNewsletterPrint Subscription

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

AACR Annual Meeting 2021
Acute Lymphoblastic Leukemia
ASH Leukemia
ASH Street Team
Biochemical Recurrence in Prostate Cancer
R/R HER2+ Metastatic Breast Cancer Case Review

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Omar Alhalabi, MD | Authors

Articles

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer

January 17, 2019

In this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.